The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab + intravesical BCG (Bacillus Calmette-Guerin) in high-risk non-muscle invasive bladder cancer (NMIBC) patients: Institutional clinical and translational study (BladderGATE).
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Guillermo de Velasco
Honoraria - Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; MSD; Novartis; Pfizer
Research Funding - Ipsen
Other Relationship - Janssen
 
Maria Cruz Martin Soberón
No Relationships to Disclose
 
Alberto Carretero-González
No Relationships to Disclose
 
Marta Dueñas
No Relationships to Disclose
 
Jesus Paramio
No Relationships to Disclose
 
Federico De La Rosa
No Relationships to Disclose
 
Juan Luis Sanz
No Relationships to Disclose
 
Félix Guerrero
Consulting or Advisory Role - Taris BioMedical
Speakers' Bureau - Alexion Pharmaceuticals; AstraZeneca; Novartis; Pfizer; Recordati; ROVI; Taris BioMedical
Travel, Accommodations, Expenses - Almirall; Astellas Pharma; Ipsen; Lacer; Pfizer; QPharma; Recordati; ROVI